Skip to main content
Clinical Trials/NCT06437795
NCT06437795
Active, not recruiting
Not Applicable

Effectiveness of Dry Needling Versus Cupping Therapy for Pain in Piriformis Syndrome

Superior University1 site in 1 country80 target enrollmentNovember 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Piriformis Syndrome
Sponsor
Superior University
Enrollment
80
Locations
1
Primary Endpoint
Visual Analog Scale (VAS)
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to compare the effectiveness of two popular therapeutic interventions, dry needling and cupping therapy, in alleviating pain associated with Piriformis Syndrome. Piriformis Syndrome is a neuromuscular disorder caused by the compression or irritation of the sciatic nerve by the piriformis muscle, leading to buttock pain and radiating numbness.

Detailed Description

The study will recruit participants diagnosed with Piriformis Syndrome and will randomly assign them to receive either dry needling or cupping therapy over a specific period. The primary outcome will be the reduction in pain intensity measured by standardized pain assessment tools. Secondary outcomes will include improvements in functional mobility and quality of life. By analyzing the efficacy and patient-reported outcomes of both therapies, the study aims to provide evidence-based recommendations for clinicians treating Piriformis Syndrome.

Registry
clinicaltrials.gov
Start Date
November 1, 2023
End Date
September 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Muhammad Naveed Babur

Principal Investigator

Superior University

Eligibility Criteria

Inclusion Criteria

  • Adults aged between 18 to 65 years.
  • Diagnosed with piriformis syndrome.
  • Experiencing chronic pain for at least 3 months.
  • Willingness to comply with the study protocol and attend all therapy sessions.

Exclusion Criteria

  • Recent surgery on the lower back or hip.
  • Presence of systemic diseases affecting muscle function (e.g., multiple sclerosis, rheumatoid arthritis).
  • Pregnant or breastfeeding women.
  • Use of anticoagulant medication or having a bleeding disorder.
  • Participating in another clinical trial simultaneously

Outcomes

Primary Outcomes

Visual Analog Scale (VAS)

Time Frame: 12 Months

Participants will rate their pain on a scale from 0 (no pain) to 10 (worst possible pain) at the beginning and end of the study.

Oswestry Disability Index (ODI)

Time Frame: 12 months

This tool assesses the degree of disability in performing daily activities. Quality of life improvements measured by the SF-36 Health Survey, which evaluates physical and mental health status.

Study Sites (1)

Loading locations...

Similar Trials